Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Thermosome GmbH
Washington University School of Medicine
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
National Cancer Institute (NCI)
City of Hope Medical Center
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center